Alejandro Díaz-Borjón

550 total citations
16 papers, 366 citations indexed

About

Alejandro Díaz-Borjón is a scholar working on Rheumatology, Oncology and Molecular Biology. According to data from OpenAlex, Alejandro Díaz-Borjón has authored 16 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Alejandro Díaz-Borjón's work include Rheumatoid Arthritis Research and Therapies (5 papers), Drug Transport and Resistance Mechanisms (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Alejandro Díaz-Borjón is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (5 papers), Drug Transport and Resistance Mechanisms (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Alejandro Díaz-Borjón collaborates with scholars based in Mexico and United States. Alejandro Díaz-Borjón's co-authors include Cornelia M. Weyand, Jörg J. Goronzy, Luis Llorente, Yvonne Richaud‐Patín, Juan Jakez-Ocampo, Hiroshi Fujii, Inés Colmegna, E Díaz-Jouanen, Roberto González‐Amaro and Claudia Alvarado‐de la Barrera and has published in prestigious journals such as The American Journal of Medicine, Clinical & Experimental Immunology and Experimental Gerontology.

In The Last Decade

Alejandro Díaz-Borjón

15 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alejandro Díaz-Borjón Mexico 9 102 88 76 72 64 16 366
Nicola Farina Italy 13 70 0.7× 128 1.5× 86 1.1× 169 2.3× 48 0.8× 30 459
Ottavia Magnani Italy 8 48 0.5× 97 1.1× 211 2.8× 37 0.5× 67 1.0× 10 418
Cathy Chognot Switzerland 6 98 1.0× 33 0.4× 136 1.8× 155 2.2× 47 0.7× 12 556
Shigeo Nishimata Japan 10 64 0.6× 34 0.4× 97 1.3× 55 0.8× 97 1.5× 36 379
Sean Deane United States 7 61 0.6× 33 0.4× 96 1.3× 42 0.6× 46 0.7× 7 373
Antonio Barat Spain 11 84 0.8× 54 0.6× 48 0.6× 85 1.2× 125 2.0× 16 481
Gürses Şahin Türkiye 12 69 0.7× 47 0.5× 37 0.5× 30 0.4× 26 0.4× 45 372
Sara Mohamed Egypt 8 79 0.8× 195 2.2× 276 3.6× 44 0.6× 33 0.5× 39 566

Countries citing papers authored by Alejandro Díaz-Borjón

Since Specialization
Citations

This map shows the geographic impact of Alejandro Díaz-Borjón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Díaz-Borjón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Díaz-Borjón more than expected).

Fields of papers citing papers by Alejandro Díaz-Borjón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandro Díaz-Borjón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Díaz-Borjón. The network helps show where Alejandro Díaz-Borjón may publish in the future.

Co-authorship network of co-authors of Alejandro Díaz-Borjón

This figure shows the co-authorship network connecting the top 25 collaborators of Alejandro Díaz-Borjón. A scholar is included among the top collaborators of Alejandro Díaz-Borjón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandro Díaz-Borjón. Alejandro Díaz-Borjón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Vega‐Morales, David, Jorge Antonio Esquivel‐Valerio, Alejandro Díaz-Borjón, et al.. (2021). Comorbidity burden in terms of disability in patients with osteoarthritis in Mexico. The IMPACTAR registry. Reumatología Clínica (English Edition). 17(8). 440–446. 3 indexed citations
2.
Díaz-Borjón, Alejandro, et al.. (2021). Adherence to current vaccination recommendations for patients with rheumatoid arthritis in Mexico. Reumatología Clínica (English Edition). 17(3). 155–159. 4 indexed citations
3.
Vega‐Morales, David, Jorge Antonio Esquivel‐Valerio, Alejandro Díaz-Borjón, et al.. (2020). Comorbidity burden in terms of disability in patients with osteoarthritis in Mexico. The IMPACTAR registry. Reumatología Clínica. 17(8). 440–446. 2 indexed citations
4.
Díaz-Borjón, Alejandro, et al.. (2019). Adherencia a las recomendaciones actuales de inmunización en pacientes con artritis reumatoide en México. Reumatología Clínica. 17(3). 155–159. 4 indexed citations
5.
Díaz-Borjón, Alejandro, et al.. (2017). [Osteoarthrosis: implementation of current diagnostic and therapeutic algorithms].. PubMed. 55(1). 67–75. 3 indexed citations
6.
Díaz-Jouanen, E, et al.. (2011). Parvovirus B19–Associated Arthritis. JCR Journal of Clinical Rheumatology. 17(8). 449–450. 8 indexed citations
7.
Díaz-Borjón, Alejandro. (2009). Guidelines for the Use of Conventional and Newer Disease-Modifying Antirheumatic Drugs in Elderly Patients with Rheumatoid Arthritis. Drugs & Aging. 26(4). 273–293. 24 indexed citations
8.
Colmegna, Inés, et al.. (2008). Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis. Arthritis & Rheumatism. 58(4). 990–1000. 83 indexed citations
9.
Díaz-Borjón, Alejandro, et al.. (2006). Bisphosphonate-Associated Arthritis. JCR Journal of Clinical Rheumatology. 12(3). 131–133. 11 indexed citations
10.
Franco‐Paredes, Carlos, et al.. (2006). The Ever-Expanding Association Between Rheumatologic Diseases and Tuberculosis. The American Journal of Medicine. 119(6). 470–477. 38 indexed citations
11.
Díaz-Borjón, Alejandro, Cornelia M. Weyand, & Jörg J. Goronzy. (2006). Treatment of chronic inflammatory diseases with biologic agents: Opportunities and risks for the elderly. Experimental Gerontology. 41(12). 1250–1255. 13 indexed citations
12.
Llorente, Luis, Hortensia de la Fuente, Yvonne Richaud‐Patín, et al.. (2000). Innate immune response mechanisms in non-insulin dependent diabetes mellitus patients assessed by flow cytoenzymology. Immunology Letters. 74(3). 239–244. 50 indexed citations
13.
Llorente, Luis, Yvonne Richaud‐Patín, Alejandro Díaz-Borjón, et al.. (2000). Phénotype MDR-I de multirésistance aux traitements de fond dans les maladies rhumatismales auto-immunes. Revue du Rhumatisme. 67(1). 37–47.
14.
Díaz-Borjón, Alejandro, et al.. (2000). Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part II: Increased P-glycoprotein activity in lymphocytes from systemic lupus erythematosus patients might affect steroid requirements for disease control.. PubMed. 67(1). 40–8. 40 indexed citations
15.
Llorente, Luis, Yvonne Richaud‐Patín, Alejandro Díaz-Borjón, et al.. (2000). Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part I: Increased P-glycoprotein activity in lymphocytes from rheumatoid arthritis patients might influence disease outcome.. PubMed. 67(1). 30–9. 76 indexed citations
16.
Llorente, Luis, Yvonne Richaud‐Patín, Alejandro Díaz-Borjón, Juan Jakez-Ocampo, & Claudia Alvarado‐de la Barrera. (1999). Increased collagenase and dipeptidyl peptidase I activity in leucocytes from healthy elderly people. Clinical & Experimental Immunology. 116(3). 425–429. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026